ABSTRACT
Neurocutaneous syndromes are genetic diseases that affect the nervous system and the skin. Epileptic seizures are seen with variable frequency. In the present study, data of 29 patients from 5 centers were analyzed in an effort to draw attention to the disease group.
Data of 29 patients diagnosed with neurocutaneous syndrome were retrospectively evaluated.
Study population was composed of 15 women (51.7%) and 14 men (48.3%), with a mean age of 31 (72±2.16). Ten patients (34.5%) were diagnosed with tuberous sclerosis, 9 (31%) with Sturge–Weber syndrome, 3 (10.3%) with neurofibromatosis type 1, 3 (10.3%) with neurofibromatosis type 2, 1 (3.4%) with neurocutaneous melanosis, 1 (3.4%) with hypomelanosis of Ito, 1 (3.4%) with probable Sturge–Weber syndrome, and 1 patient was diagnosed with unclassified neurocutaneous syndrome. One patient did not receive antiepileptic treatment, 9 (31%) received monotherapy, and 19 (65.5%) received polytherapy. Carbamazepine was the most commonly used medication.
Attention is drawn to the prevalence of neurocutaneous syndrome in epileptic adults, with seizure frequency depending on syndrome type.
Keywords: Epilepsy, seizure, neurocutaneous syndromes